TY - JOUR
T1 - Ethical issues in medical cannabis use
AU - Sagy, Iftach
AU - Peleg-Sagy, Tal
AU - Barski, Leonid
AU - Zeller, Lior
AU - Jotkowitz, Alan
N1 - Publisher Copyright:
© 2018 European Federation of Internal Medicine
PY - 2018/3/1
Y1 - 2018/3/1
N2 - The increasing use of medical cannabis (MC) in the past decade raises several ethical considerations for the clinician. Regulatory issues stem from a gap between MC registration and certification in each country. Professional issues derive from the lack of sufficient knowledge of MC characteristics and the intersection between the physician, the patient and commercial interests. Finally, there are medical and psychological implications which are related to the use of MC regimens. We will discuss these issues in the light of the current era, in which policy has rapidly shifted toward legalization of cannabis, which influences the decisions of both clinicians and patients.
AB - The increasing use of medical cannabis (MC) in the past decade raises several ethical considerations for the clinician. Regulatory issues stem from a gap between MC registration and certification in each country. Professional issues derive from the lack of sufficient knowledge of MC characteristics and the intersection between the physician, the patient and commercial interests. Finally, there are medical and psychological implications which are related to the use of MC regimens. We will discuss these issues in the light of the current era, in which policy has rapidly shifted toward legalization of cannabis, which influences the decisions of both clinicians and patients.
KW - Ethical considerations
KW - Medical cannabis
UR - http://www.scopus.com/inward/record.url?scp=85042349915&partnerID=8YFLogxK
U2 - 10.1016/j.ejim.2018.01.016
DO - 10.1016/j.ejim.2018.01.016
M3 - Review article
AN - SCOPUS:85042349915
SN - 0953-6205
VL - 49
SP - 20
EP - 22
JO - European Journal of Internal Medicine
JF - European Journal of Internal Medicine
ER -